Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics

Abstract excerpt

Targeting cancer-specific HLA-peptide complexes is a promising approach in immunotherapy. Mutated neoantigens are excellent targets due to their immunogenicity and cancer-specificity. Mass spectrometry (MS)-based immunopeptidomics guides the selection of naturally presented immunogenic targets within the immunopeptidome, refining immunogenicity predictions. Implementation in clinical settings, however, must...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Biosensing Techniques and Applications
• Share to Monoclonal and Polyclonal Antibodies Research
• Share to vaccines and immunoinformatics approaches